Gene: DST

667
BP240|BPA|BPAG1|CATX-15|CATX15|D6S1101|DMH|DT|EBSB2|HSAN6|MACF2
dystonin
protein-coding
6p12.1
Ensembl:ENSG00000151914 MIM:113810 Vega:OTTHUMG00000014913 UniprotKB:Q03001
NG_029322.2
PubMed
0   ANCO-SNPs
ND|AD
10   
NA (AD)  NA (ND)   (Frontal_Cortex)
4.263e-1 (AD)  3.505e-1 (ND)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg15373592chr6:56405167DSTGene body8.913e-5Alcohol use disorders26763658

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
PHF30.857
MON1B0.856
CEP1040.854
FMNL20.848
NIPBL0.845
TEX20.842
WDFY30.842
SNX190.84
ARAP20.84
BAZ1B0.836

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F29-0.588
OR4F5-0.559
CRH-0.265
SPRR2B-0.253
OR4F16-0.231
VGF-0.227
C17orf112-0.223
SLC17A3-0.222
IBSP-0.217
PAX2-0.215

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0235142,6-dinitrotoluene"2,6-dinitrotoluene affects the expression of DST mRNA"21346803
C0144643,4-dichloroaniline"3,4-dichloroaniline results in decreased expression of DST mRNA"24172598
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DST mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DST mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DST mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DST mRNA"27188386
C0275764-hydroxy-2-nonenal4-hydroxy-2-nonenal results in decreased expression of DST mRNA12419474
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DST mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DST mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DST mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DST mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of DST mRNA21420995
D000082AcetaminophenAcetaminophen affects the expression of DST mRNA17562736
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of DST gene27153756
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of DST mRNA21641981|2715375
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of DST mRNA19770486
D000966Antimony Potassium TartrateAntimony Potassium Tartrate results in decreased expression of DST protein28713220
D018501Antirheumatic AgentsAntirheumatic Agents results in increased expression of DST mRNA24449571
C006632arsenic trioxidearsenic trioxide results in increased expression of DST mRNA22521957
D017638Asbestos, Crocidolite"Asbestos, Crocidolite results in decreased expression of DST mRNA"25351596
D001280AtrazineAtrazine results in decreased expression of DST mRNA25929836
C030935benz(a)anthracenebenz(a)anthracene results in decreased expression of DST mRNA26377693
C022921benzo(k)fluoranthenebenzo(k)fluoranthene results in decreased expression of DST mRNA26377693
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of DST mRNA20064835
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of DST mRNA21871943
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of DST mRNA19770486
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of DST mRNA22228805
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DST mRNA"19150397
D004958Estradiol[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of DST mRNA19619570
D004958EstradiolEstradiol results in increased expression of DST mRNA19619570
C543008bis(4-hydroxyphenyl)sulfone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of DST mRNA28628672
C006780bisphenol Abisphenol A results in decreased expression of DST mRNA22576693
C006780bisphenol Abisphenol A results in increased methylation of DST gene22576693
C006780bisphenol A[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DST mRNA28628672
C000611646bisphenol F[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of DST mRNA28628672
D000069286BortezomibBortezomib results in increased expression of DST mRNA17659339
C013418bromfenacoumbromfenacoum results in increased expression of DST protein28903499
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide results in decreased expression of DST mRNA12419474
D002104CadmiumCadmium affects the expression of DST mRNA21120746
D020111Chlorodiphenyl (54% Chlorine)Chlorodiphenyl (54% Chlorine) results in decreased expression of DST mRNA23650126
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DST mRNA20938992
D003010ClorgylineClorgyline results in increased expression of DST mRNA19691856
D003300Copper[NSC 689534 binds to Copper] which results in increased expression of DST mRNA20971185
D019327Copper SulfateCopper Sulfate results in increased expression of DST mRNA19549813
C030973cupric oxidecupric oxide results in decreased expression of DST mRNA22077320
D016572CyclosporineCyclosporine results in increased expression of DST mRNA25562108
D016572CyclosporineCyclosporine results in increased methylation of DST promoter27989131
D003907DexamethasoneDexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of DST mRNA]27941970
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of DST mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DST mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of DST mRNA28628672
D003993Dibutyl PhthalateDibutyl Phthalate results in increased expression of DST mRNA17361019
D002945Cisplatin[Cisplatin co-treated with Paclitaxel] affects the expression of DST mRNA20705681
D002945CisplatinDST protein affects the susceptibility to Cisplatin16217747
D004026DieldrinDieldrin affects the expression of DST mRNA22546817
C045651epigallocatechin gallate[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DST mRNA22079256
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of DST mRNA17555576
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of DST mRNA17942748
D004997Ethinyl EstradiolEthinyl Estradiol results in decreased expression of DST mRNA17557909
D005038EthylnitrosoureaEthylnitrosourea results in increased mutagenesis of DST gene16724327
D005472FluorouracilDST protein affects the susceptibility to Fluorouracil16217747
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DST mRNA20938992
D005557FormaldehydeFormaldehyde results in decreased expression of DST mRNA20655997|2364984
C070081fulvestrantfulvestrant results in increased expression of DST mRNA16202921
C001277geldanamycingeldanamycin results in increased expression of DST mRNA26705709
D017313FenretinideFenretinide results in decreased expression of DST mRNA28973697
D007213IndomethacinIndomethacin results in decreased expression of DST mRNA16984733
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of DST mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DST mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of DST mRNA28628672
C051890irinotecanirinotecan analog results in decreased expression of DST mRNA18927307
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of DST mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DST mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of DST mRNA28628672
C544151jinfukangjinfukang results in decreased expression of DST mRNA27392435
D007854LeadLead affects the splicing of DST mRNA28903495
C045463leflunomideleflunomide results in increased expression of DST mRNA24136188
D008558MelphalanMelphalan results in decreased expression of DST mRNA22363485
D008694MethamphetamineMethamphetamine results in increased expression of DST mRNA26307267
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DST mRNA20938992
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of DST mRNA28001369
D018817N-Methyl-3,4-methylenedioxyamphetamine"N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of DST mRNA"26251327
C070571ML 7ML 7 affects the localization of DST protein14691950
C016599mono-(2-ethylhexyl)phthalatemono-(2-ethylhexyl)phthalate results in increased expression of DST mRNA22401849
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of DST mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of DST mRNA"25554681
D009532NickelNickel results in decreased expression of DST mRNA25583101
C022838nickel chloridenickel chloride affects the expression of DST mRNA22546817
C028007nickel monoxidenickel monoxide results in increased expression of DST mRNA19167457
C558013NSC 689534[NSC 689534 binds to Copper] which results in increased expression of DST mRNA20971185
C030110oxaliplatin[oxaliplatin co-treated with Topotecan] results in increased expression of DST mRNA25729387
C030110oxaliplatinoxaliplatin results in increased expression of DST mRNA25729387
D010100OxygenOxygen deficiency results in increased expression of DST mRNA24236059
D010100OxygenOxygen deficiency affects the methylation of DST promoter24205000
D010100OxygenOxygen deficiency results in increased expression of DST mRNA24205000
D017239Paclitaxel[Cisplatin co-treated with Paclitaxel] affects the expression of DST mRNA20705681
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DST mRNA"27188386
C496932panobinostatpanobinostat results in decreased expression of DST mRNA26272509
C058305phenethyl isothiocyanatephenethyl isothiocyanate results in decreased expression of DST mRNA17616710
D010634PhenobarbitalNR1I3 protein affects the reaction [Phenobarbital results in increased expression of DST mRNA]19482888
D010634PhenobarbitalPhenobarbital results in increased expression of DST mRNA19482888
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DST mRNA"27188386
C006253pirinixic acidpirinixic acid results in decreased expression of DST mRNA23811191
C006253pirinixic acidpirinixic acid results in increased expression of DST mRNA18445702
D010936Plant ExtractsPlant Extracts results in increased expression of DST mRNA23557933
C027373potassium chromate(VI)[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DST mRNA22079256
C027373potassium chromate(VI)potassium chromate(VI) results in decreased expression of DST mRNA22079256
D011192Potassium DichromatePotassium Dichromate results in increased expression of DST protein23718831
D011192Potassium DichromatePotassium Dichromate results in decreased expression of DST mRNA23608068
D011374ProgesteroneProgesterone results in decreased expression of DST mRNA20631399
D011374ProgesteroneProgesterone results in decreased expression of DST mRNA18070364
C043680ptaquilosideptaquiloside results in decreased expression of DST mRNA23274088
D012645SelenomethionineSelenomethionine affects the expression of DST mRNA17222674
C078903seocalcitolseocalcitol results in increased expression of DST mRNA12040012
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of DST mRNA25895662
D012906SmokeSmoke results in decreased expression of DST mRNA21095227
C009277sodium arsenatesodium arsenate results in decreased expression of DST mRNA21795629
C009277sodium arsenatesodium arsenate results in increased expression of DST mRNA21795629
C016104sodium bichromatesodium bichromate affects the expression of DST mRNA22110744
C061133tamibarotenetamibarotene results in decreased expression of DST mRNA15498508
D013629TamoxifenTamoxifen results in increased expression of DST mRNA16202921
D013629TamoxifenTamoxifen affects the expression of DST mRNA17555576
D013749Tetrachlorodibenzodioxin[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of DST mRNA19619570
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of DST mRNA23152189
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of DST mRNA19619570|2791314
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of DST mRNA21570461|2468072
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of DST mRNA27913140
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of DST mRNA27913140
D013849ThimerosalThimerosal affects the expression of DST mRNA27188386
C009495titanium dioxidetitanium dioxide results in increased expression of DST mRNA19695317
D019772Topotecan[oxaliplatin co-treated with Topotecan] results in increased expression of DST mRNA25729387
D019772TopotecanTopotecan results in increased expression of DST mRNA25729387
C483909torcetrapibtorcetrapib results in increased expression of DST mRNA23228038
D014212TretinoinTretinoin results in decreased expression of DST mRNA15498508
C011559tributyltintributyltin results in decreased expression of DST mRNA27614199
D014241TrichloroethyleneTrichloroethylene results in increased methylation of DST gene27618143
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DST mRNA"27188386
C012589trichostatin Atrichostatin A results in decreased expression of DST mRNA24935251|2627250
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in increased expression of DST mRNA"26179874
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DST mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of DST mRNA23179753|2597931
D014635Valproic AcidValproic Acid results in decreased expression of DST mRNA24383497|2627250
D014635Valproic AcidValproic Acid results in decreased methylation of DST gene29154799
D014635Valproic AcidValproic Acid results in increased expression of DST mRNA27188386
D001335Vehicle EmissionsVehicle Emissions affects the methylation of DST gene25560391
C025643vinclozolinvinclozolin affects the expression of DST mRNA19015723
C111237vorinostatvorinostat results in decreased expression of DST mRNA27188386
C108830Y 27632Y 27632 affects the localization of DST protein14691950

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0003779actin binding-IEA-  
GO:0005178integrin binding-IPI11375975  
GO:0005198structural molecule activity-IBA21873635  
GO:0005509calcium ion binding-IEA-  
GO:0005515protein binding-IPI12482924  17043677  19632184  19932097  21911577  22995871  
23414517  26496610  
GO:0008017microtubule binding-IBA21873635  
GO:0008022protein C-terminus binding-IPI11375975  
GO:0045296cadherin binding-IBA21873635  
GO:0051010microtubule plus-end binding-IDA19632184  
GO ID GO Term Qualifier Evidence PubMed
GO:0007010cytoskeleton organization-IMP19403692  
GO:0007155cell adhesion-IEA-  
GO:0007229integrin-mediated signaling pathway-NAS11375975  
GO:0008090retrograde axonal transport-ISS-  
GO:0009611response to wounding-IDA19403692  
GO:0030011maintenance of cell polarity-IMP19403692  
GO:0031122cytoplasmic microtubule organization-IBA21873635  
GO:0031581hemidesmosome assembly-IBA21873635  
GO:0042060wound healing-IBA21873635  
GO:0045104intermediate filament cytoskeleton organization-IBA21873635  
GO:0045104intermediate filament cytoskeleton organization-IEP11751855  
GO:0045104intermediate filament cytoskeleton organization-ISS-  
GO:0045104intermediate filament cytoskeleton organization-NAS11375975  
GO:0048870cell motility-IMP19403692  
GO ID GO Term Qualifier Evidence PubMed
GO:0005604basement membrane-TAS2461961  
GO:0005634nucleus-HDA21630459  
GO:0005634nucleus-IDA-  
GO:0005635nuclear envelope-IEA-  
GO:0005737cytoplasm-IBA21873635  
GO:0005737cytoplasm-IDA11751855  
GO:0005737cytoplasm-ISS-  
GO:0005789endoplasmic reticulum membrane-IEA-  
GO:0005829cytosol-IDA-  
GO:0005829cytosol-TAS-  
GO:0005882intermediate filamentCOLOCALIZES_WITHIBA21873635  
GO:0005882intermediate filament-IEA-  
GO:0005925focal adhesion-HDA21423176  
GO:0005925focal adhesion-IBA21873635  
GO:0005938cell cortex-IEA-  
GO:0009925basal plasma membrane-NAS11375975  
GO:0015630microtubule cytoskeleton-IDA-  
GO:0016020membrane-IBA21873635  
GO:0016021integral component of membrane-IEA-  
GO:0030018Z disc-IEA-  
GO:0030056hemidesmosome-IBA21873635  
GO:0030056hemidesmosome-TAS8575775  11375975  
GO:0031252cell leading edge-IDA19403692  
GO:0031410cytoplasmic vesicle-IDA14581450  
GO:0031673H zone-IEA-  
GO:0035371microtubule plus-end-IDA19632184  
GO:1904115axon cytoplasm-IEA-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-1474244Extracellular matrix organizationTAS
R-HSA-1474290Collagen formationTAS
R-HSA-1500931Cell-Cell communicationTAS
R-HSA-2022090Assembly of collagen fibrils and other multimeric structuresTAS
R-HSA-446107Type I hemidesmosome assemblyTAS
R-HSA-446728Cell junction organizationTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
17086345Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior. (2006 Oct 31)Sher LScientificWorldJournal
2543997Endocrinological studies in alcoholics during withdrawal and after abstinence. (1989)Muller NPsychoneuroendocrinology
2668989Depressive disorders in children and adolescents. (1989 Jun)Simeon JGPsychiatr J Univ Ott
22050701Cigarette smoke exposure hinders long-term allograft survival by suppressing indoleamine 2, 3-dioxygenase expression. (2012 Mar)Wan FAm J Transplant
29176595The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test. (2017 Dec)Arruda MJ Hum Hypertens
6871563Abnormal dexamethasone suppression test in normal females. (1983 May)Hallstrom TBr J Psychiatry
6424482Specificity of the DST and the TRH test for major depression in alcoholics. (1984 May)Dackis CAAm J Psychiatry
14604602Nicotine withdrawal induces subsensitivity of hypothalamic-pituitary-adrenal axis to stress in rats: implications for precipitation of depression during smoking cessation. (2004 Feb)Semba JPsychoneuroendocrinology
16639867Modified dexamethasone suppression-corticotropin-releasing hormone stimulation test: A pilot study of young healthy volunteers and implications for alcoholism research in adolescents and young adults. (2006 Jan-Mar)Sher LInt J Adolesc Med Health
6412261The thyrotropin-releasing hormone and dexamethasone suppression tests in the familial classification of depression. (1983 May)Fleming JEPsychiatry Res